# Neptune Krill Oil (NKO™) in Early Stage Alzheimer's Disease (MNEMOSYNE)

> **NCT00867828** · PHASE4 · COMPLETED · sponsor: **NeuroBioPharm Inc.** · enrollment: 175 (actual)

## Conditions studied

- Early Onset Alzheimer Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Neptune Krill Oil
- **DIETARY_SUPPLEMENT:** Fish Oil
- **DIETARY_SUPPLEMENT:** Placebo (soy oil)

## Key facts

- **NCT ID:** NCT00867828
- **Lead sponsor:** NeuroBioPharm Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2010-07
- **Final completion:** 2011-01
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2011-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00867828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00867828, "Neptune Krill Oil (NKO™) in Early Stage Alzheimer's Disease (MNEMOSYNE)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00867828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*